Rasbach Kyle bought LXEO
January 17, 2025 · Form 4 insider transaction
Rasbach Kyle bought 245,250 shares of Lexeo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
245,250
Price
$0.00
Total value
N/A
InsiderRasbach Kyle
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 17, 2025
Filing dateJanuary 22, 2025
Shares owned after245,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying the option vest and become exercisable on December 18, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.